CAS: 115334-04-8; (9R,10R,13S,14S,17R)-17-((2S,4R,5S)-4,5-Dihydroxy-6-Methoxy-6-Methylheptan-2-yl)-4,4,10,13,14-Pentamethyl-1,2,4,5,6,9,10,11,12,13,14,15,16,17-Tetradecahydro-3H-Cyclopenta[a]Phenanthren-3-One

结构式图片

合成工艺路线路线简述

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Stimolo C, Favero VD, Zecchinato G, Buson R, Cusin D, Pellachin P, Simonetto P. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre. Clin Drug Investig. 2010;30 Suppl
    1:27-31. doi: 10.2165/11536030-000000000-00000.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知